Experiences with Langerhans' cell histiocytosis in children in Hungary;Gyermekkori Langerhans-sejtes histiocytosissal szerzett magyarországi tapasztalataink

Magyar Onkologia

Volumn 48, Issue 4, 2004, Pages 289-295

  Judit, Müller ^a   Rozália, Koós ^a   Miklós, Garami ^a   Péter, Hauser ^a   Gábor, Borgulya ^a   Dezsǒ, Schuler ^a   Gábor, Benyó ^b   Edina, Magyarosy ^b   Ilona, Galántai ^b   Krisztina, Milei ^b   Katalin, Török ^c   Edit, Bárdi ^b   Katalin, Hunyadi ^d   Krisztina, Gábor ^e   Péter, Masáth ^f   László, Bodnár ^b,g  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SE Isz Gyermekklinika ^*  (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d BAZ Megyei Kórház Gyermekegészségügyi Központ   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

^f Markusovszky Kórház Gyermekosztálya   (Hungary)

^g Szent László Secondary School   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; DISEASE COURSE; FEMALE; HISTIOCYTOSIS X; HUMAN; HUNGARY; INCIDENCE; INFANT; MALE; PRESCHOOL CHILD; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; HUNGARY; INCIDENCE; INFANT; MALE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 15744395891     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Broadbent V, Gadner H, Komp DM, et al. Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Med Pediatr Oncol 17:492-495, 1989
2. Chu T, D'Angio GJ, Favara B, et al. Histiocytosis syndromes in children. Lancet 1:208-209, 1987
3. Chu T. Langerhans cell histiocytosis. Australas J Dermatol 42:237-242, 2001
4. de Graaf JH, Egeler RM: New insights into the pathogenesis of Langerhans cell histiocytosis. Curr Opin Pediatr 9:46-50, 1997
5. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 127:1-11, 1995
6. Favara BE, Feller AC. Contemporary classification of Hhstiocytosis disorders. Med Pediatr Oncol 39:157-166, 1997
7. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 138:728-734, 2001
8. Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis. Cancer 85:2278-2290, 1999
9. Howath DM, Mullan BP, Wisemann GA, et al. Bone scintigraphy evaluated in diagnosis and staging Langerhans' cell histiocytosis and related disorders. J Nucl Med 37:1456-1460, 1996
10. Kilborn TN, The J, Goodman TR: Paediatric manifestations of Langerhans cell histiocytosis: a Review of the clinical and radiological findings. Clin Radiol 58:269-278, 2003
11. Kôhalmi F, Strausz J, Egervary M, et al. Differential expression of markers in extensive restrict Langerhans cell histiocytosis (LCH). Pathol Oncol Res 2:184-187, 1996
12. Kôhalmi F, Strausz J, Egervary M, et al. Expression of macrophage markers in childhood and adult Langerhans histiocytosis (LCH). Orvosi Hetilap 138:1399-1402, 1997
13. Kusumakumary P, James FV, Chellam VG, et al. Disseminated Langerhans cell histocytosis in children: treatment outcome. Am J Clin Oncol 22:180-183, 1999
14. Ladisch S. Langerhans histiocytosis. Curr Opin Hematol 5:54-58, 1998
15. Langerhans P: Über die Nerven der menschlichen Haut. Virchows Arch Abl B Pathol 44:325-337, 1868
16. Lichtenstein L. Histiocytosis X, integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Schüller-Christian disease as related manifestations of a single nosologic entity. Arch Patol 56:84-102, 1953
17. Lahey ME. Histicytosis X-an analysis of prognostic factors. J Pediatr 87: 184-189, 1975
18. Minkov M, Grois N, Heitger A, et al. Response to initial treatment of multisystem Langerhans cell histiocytosis: An important prognostic indicator. Med Pediatr Oncol 39:581-585, 2002
19. Nagarajan R, Neglia J, Ramsay N, et al. Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. J Pediatr Hematol Oncol 23: 629-632, 2001
20. Nezelof C, Basset F. Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 12:385-406, 1998
21. Stine KC, Saylors Rl, Wiliams LL, et al. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 329: 734-735, 1997
22. Suminoe A, Matsuzaki A, Hattori H, et al. Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. J Pediatr Hematol Oncol 23:633-636, 2001
23. Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83-and 90-Study. Med Pediatr Oncol 37:108-114, 2001
24. Török É, Király L, Walcz E. Csecsemôkori histiocytosis syndroma (histiocytosis X). Orv Hetil 125:2611-2614, 1984
25. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 331:154-160, 1994
26. Zelger B: Langerhans cell histiocytosis: a reactive or neoplastic disorder? Med Pediatr Oncol 37:543-544, 2001
27. Zeller B, Storm-Mathisen I, Smevik B, et al. Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement-good response to cyclosporine A. Med Pediatr Oncol 35:438-442, 2000